Annual Shareholders Equity
$3.31 M
-$7.24 M-68.60%
December 1, 2023
Summary
- As of February 7, 2025, NBY annual stockholders equity is $3.31 million, with the most recent change of -$7.24 million (-68.60%) on December 1, 2023.
- During the last 3 years, NBY annual shareholders equity has fallen by -$9.00 million (-73.10%).
- NBY annual shareholders equity is now -76.86% below its all-time high of $14.32 million, reached on December 31, 2007.
Performance
NBY Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$1.07 M
+$1.69 M+273.74%
September 1, 2024
Summary
- As of February 7, 2025, NBY quarterly stockholders equity is $1.07 million, with the most recent change of +$1.69 million (+273.74%) on September 1, 2024.
- Over the past year, NBY quarterly shareholders equity has dropped by -$5.96 million (-84.77%).
- NBY quarterly shareholders equity is now -93.96% below its all-time high of $17.75 million, reached on March 31, 2022.
Performance
NBY Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
NBY Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -68.6% | -84.8% |
| 3 y3 years | -73.1% | -87.5% |
| 5 y5 years | -33.1% | -87.5% |
NBY Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -68.6% | at low | -94.0% | +273.7% |
| 5 y | 5-year | -73.1% | +240.6% | -94.0% | +273.7% |
| alltime | all time | -76.9% | +165.0% | -94.0% | +114.7% |
NovaBay Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.07 M(-273.7%) |
| Jun 2024 | - | -$617.00 K(-485.6%) |
| Mar 2024 | - | $160.00 K(-95.2%) |
| Dec 2023 | $3.31 M(-68.6%) | $3.31 M(-52.9%) |
| Sep 2023 | - | $7.04 M(-17.8%) |
| Jun 2023 | - | $8.56 M(-3.7%) |
| Mar 2023 | - | $8.89 M(-15.8%) |
| Dec 2022 | $10.55 M(+3.8%) | $10.55 M(-23.4%) |
| Sep 2022 | - | $13.78 M(-12.5%) |
| Jun 2022 | - | $15.74 M(-11.3%) |
| Mar 2022 | - | $17.75 M(+74.5%) |
| Dec 2021 | $10.17 M(-17.4%) | $10.17 M(+8.6%) |
| Sep 2021 | - | $9.36 M(-16.5%) |
| Jun 2021 | - | $11.21 M(+2.1%) |
| Mar 2021 | - | $10.98 M(-10.8%) |
| Dec 2020 | $12.32 M(+1166.0%) | $12.32 M(-11.3%) |
| Sep 2020 | - | $13.88 M(+1312.2%) |
| Jun 2020 | - | $983.00 K(-381.7%) |
| Mar 2020 | - | -$349.00 K(-135.9%) |
| Dec 2019 | $973.00 K(-80.4%) | $973.00 K(-66.7%) |
| Sep 2019 | - | $2.92 M(+75.1%) |
| Jun 2019 | - | $1.67 M(+47.8%) |
| Mar 2019 | - | $1.13 M(-77.2%) |
| Dec 2018 | $4.95 M(+91.0%) | $4.95 M(-18.2%) |
| Sep 2018 | - | $6.06 M(-18.4%) |
| Jun 2018 | - | $7.43 M(-16.3%) |
| Mar 2018 | - | $8.87 M(+242.0%) |
| Dec 2017 | $2.59 M(-63.5%) | $2.59 M(+41.6%) |
| Sep 2017 | - | $1.83 M(-42.9%) |
| Jun 2017 | - | $3.21 M(-26.3%) |
| Mar 2017 | - | $4.36 M(-38.7%) |
| Dec 2016 | $7.10 M(-239.3%) | $7.10 M(+5.7%) |
| Sep 2016 | - | $6.72 M(-372.3%) |
| Jun 2016 | - | -$2.47 M(-66.2%) |
| Mar 2016 | - | -$7.30 M(+43.2%) |
| Dec 2015 | -$5.10 M | -$5.10 M(-2345.8%) |
| Sep 2015 | - | $227.00 K(-95.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $4.90 M(+128.2%) |
| Mar 2015 | - | $2.15 M(+16.3%) |
| Dec 2014 | $1.85 M(-78.3%) | $1.85 M(-67.5%) |
| Sep 2014 | - | $5.69 M(-38.3%) |
| Jun 2014 | - | $9.22 M(-22.1%) |
| Mar 2014 | - | $11.84 M(+39.0%) |
| Dec 2013 | $8.52 M(-39.4%) | $8.52 M(+57.1%) |
| Sep 2013 | - | $5.42 M(-24.8%) |
| Jun 2013 | - | $7.21 M(-30.3%) |
| Mar 2013 | - | $10.34 M(-26.4%) |
| Dec 2012 | $14.05 M(+50.4%) | $14.05 M(+88.7%) |
| Sep 2012 | - | $7.44 M(+32.6%) |
| Jun 2012 | - | $5.61 M(-23.8%) |
| Mar 2012 | - | $7.37 M(-21.1%) |
| Dec 2011 | $9.34 M(-10.9%) | $9.34 M(-27.8%) |
| Sep 2011 | - | $12.94 M(+34.3%) |
| Jun 2011 | - | $9.64 M(+7.8%) |
| Mar 2011 | - | $8.94 M(-14.8%) |
| Dec 2010 | $10.49 M(-21.4%) | $10.49 M(+5.1%) |
| Sep 2010 | - | $9.98 M(-11.8%) |
| Jun 2010 | - | $11.31 M(-7.2%) |
| Mar 2010 | - | $12.19 M(-8.7%) |
| Dec 2009 | $13.35 M(+81.7%) | $13.35 M(+39.2%) |
| Sep 2009 | - | $9.59 M(+28.6%) |
| Jun 2009 | - | $7.46 M(-0.6%) |
| Mar 2009 | - | $7.50 M(+2.1%) |
| Dec 2008 | $7.34 M(-48.7%) | $7.34 M(-14.9%) |
| Sep 2008 | - | $8.63 M(-12.7%) |
| Jun 2008 | - | $9.88 M(-17.2%) |
| Mar 2008 | - | $11.93 M(-16.7%) |
| Dec 2007 | $14.32 M(+689.9%) | $14.32 M(-652.5%) |
| Sep 2007 | - | -$2.59 M(+180.8%) |
| Jun 2007 | - | -$923.00 K(-234.4%) |
| Mar 2007 | - | $687.00 K(-62.1%) |
| Dec 2006 | $1.81 M(-44.2%) | $1.81 M(-44.2%) |
| Dec 2005 | $3.25 M(+305.5%) | $3.25 M |
| Dec 2003 | $802.00 K | - |
FAQ
- What is NovaBay Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals annual shareholders equity year-on-year change?
- What is NovaBay Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly shareholders equity year-on-year change?
What is NovaBay Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of NBY is $3.31 M
What is the all time high annual shareholders equity for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual stockholders equity is $14.32 M
What is NovaBay Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, NBY annual stockholders equity has changed by -$7.24 M (-68.60%)
What is NovaBay Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of NBY is $1.07 M
What is the all time high quarterly shareholders equity for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly stockholders equity is $17.75 M
What is NovaBay Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, NBY quarterly stockholders equity has changed by -$5.96 M (-84.77%)